Get access to leading lung cancer treatments and advanced molecular tumor testing at University of Colorado Health.
UCHealth offers some of the most sophisticated molecular tests and one of the broadest ranges of clinical trials for new treatments of lung cancer.
Screening for genetic issues
Advanced molecular testing screens tumors for genetic problems that can be targeted with specific drugs.
We offer participation in clinical trials, including experimental targeted lung cancer therapy for ALK-positive non-small cell lung cancer. Our affiliate, the University of Colorado Cancer Center, serves as the lead site for the nationwide Lung Cancer Mutation Consortium—a collaboration of 14 of the nation’s elite lung cancer programs—which offers free molecular tumor testing for certain subtypes of lung cancer.
As part of your physician visit, this testing helps match your specific type of lung cancer to the targeted treatment that best fits your situation.
Through its affiliation with the CU Cancer Center, UCHealth conducts many clinical trials of new cancer treatments or drugs.
Participation in a clinical trial may provide those who qualify with access to drugs and vaccines years before they are widely available.
Take your journey with the committed and caring team of lung cancer experts at UCHealth. For more information about our services or to make an appointment, call 720-848-0300 today.